Royal Prima PT
PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more
Royal Prima PT (PRIM) - Net Assets
Latest net assets as of September 2025: Rp955.60 Billion IDR
Based on the latest financial reports, Royal Prima PT (PRIM) has net assets worth Rp955.60 Billion IDR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp1.07 Trillion) and total liabilities (Rp111.14 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp955.60 Billion |
| % of Total Assets | 89.58% |
| Annual Growth Rate | N/A |
| 5-Year Change | 8.21% |
| 10-Year Change | 133030.04% |
| Growth Volatility | 730.84 |
Royal Prima PT - Net Assets Trend (2014–2024)
This chart illustrates how Royal Prima PT's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Royal Prima PT (2014–2024)
The table below shows the annual net assets of Royal Prima PT from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp962.38 Billion | -1.91% |
| 2023-12-31 | Rp981.10 Billion | -0.16% |
| 2022-12-31 | Rp982.66 Billion | +1.91% |
| 2021-12-31 | Rp964.21 Billion | +8.42% |
| 2020-12-31 | Rp889.35 Billion | +4.49% |
| 2019-12-31 | Rp851.17 Billion | +0.27% |
| 2018-12-31 | Rp848.87 Billion | +238.97% |
| 2017-12-31 | Rp250.42 Billion | +1964.88% |
| 2016-12-31 | Rp12.13 Billion | +1577.68% |
| 2015-12-31 | Rp722.89 Million | +134.36% |
| 2014-12-31 | Rp-2.10 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Royal Prima PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 16511436645000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp162.81 Billion | 16.93% |
| Common Stock | Rp339.34 Billion | 35.30% |
| Other Comprehensive Income | Rp2.51 Billion | 0.26% |
| Other Components | Rp456.72 Billion | 47.51% |
| Total Equity | Rp961.39 Billion | 100.00% |
Royal Prima PT Competitors by Market Cap
The table below lists competitors of Royal Prima PT ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dharma Samudera Fishing Tbk
JK:DSFI
|
$3.23 Million |
|
Seafarms Group Ltd
AU:SFG
|
$3.23 Million |
|
CPR Gomu Industrial PCL
BK:CPR
|
$3.23 Million |
|
Hiap Huat Holdings Bhd
KLSE:0160
|
$3.23 Million |
|
Bayan Mining and Minerals Ltd
AU:BMM
|
$3.23 Million |
|
LM Funding America Inc
NASDAQ:LMFA
|
$3.23 Million |
|
Tingo Group Inc.
NASDAQ:TIO
|
$3.22 Million |
|
Eguana Technologies Inc
OTCQB:EGTYF
|
$3.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Royal Prima PT's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 980,096,701,000 to 961,386,500,000, a change of -18,710,201,000 (-1.9%).
- Net loss of 18,407,912,000 reduced equity.
- Other comprehensive income decreased equity by 302,288,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp-18.41 Billion | -1.91% |
| Other Comprehensive Income | Rp-302.29 Million | -0.03% |
| Other Changes | Rp-1.00K | -0.0% |
| Total Change | Rp- | -1.91% |
Book Value vs Market Value Analysis
This analysis compares Royal Prima PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.25x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | Rp-1052.00 | Rp72.00 | x |
| 2015-12-31 | Rp363.13 | Rp72.00 | x |
| 2016-12-31 | Rp6066.07 | Rp72.00 | x |
| 2017-12-31 | Rp113.76 | Rp72.00 | x |
| 2018-12-31 | Rp293.20 | Rp72.00 | x |
| 2019-12-31 | Rp250.55 | Rp72.00 | x |
| 2020-12-31 | Rp261.82 | Rp72.00 | x |
| 2021-12-31 | Rp283.87 | Rp72.00 | x |
| 2022-12-31 | Rp289.72 | Rp72.00 | x |
| 2023-12-31 | Rp288.82 | Rp72.00 | x |
| 2024-12-31 | Rp284.58 | Rp72.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Royal Prima PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.91%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -6.15%
- • Asset Turnover: 0.28x
- • Equity Multiplier: 1.13x
- Recent ROE (-1.91%) is below the historical average (33.57%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | -13.84% | 1.41x | 0.00x | Rp-2.09 Billion |
| 2015 | 251.59% | 2.51% | 2.68x | 37.32x | Rp1.75 Billion |
| 2016 | 95.16% | 8.37% | 3.60x | 3.15x | Rp10.33 Billion |
| 2017 | 8.10% | 11.37% | 0.57x | 1.24x | Rp-4.74 Billion |
| 2018 | 2.03% | 8.40% | 0.22x | 1.08x | Rp-67.57 Billion |
| 2019 | 0.28% | 1.38% | 0.19x | 1.07x | Rp-82.63 Billion |
| 2020 | 4.30% | 14.65% | 0.27x | 1.07x | Rp-50.68 Billion |
| 2021 | 7.83% | 12.57% | 0.53x | 1.17x | Rp-20.88 Billion |
| 2022 | 2.20% | 8.24% | 0.25x | 1.05x | Rp-76.57 Billion |
| 2023 | -0.28% | -1.04% | 0.26x | 1.05x | Rp-100.76 Billion |
| 2024 | -1.91% | -6.15% | 0.28x | 1.13x | Rp-114.55 Billion |
Industry Comparison
This section compares Royal Prima PT's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $4,141,383,254,328
- Average return on equity (ROE) among peers: 0.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Royal Prima PT (PRIM) | Rp955.60 Billion | 0.00% | 0.12x | $3.23 Million |
| Bundamedik Tbk PT (BMHS) | $665.59 Billion | 4.71% | 1.10x | $23.76 Million |
| Metro Healthcare Indonesia (CARE) | $3.30 Trillion | 0.18% | 0.28x | $411.41 Million |
| Medikaloka Hermina PT (HEAL) | $2.37 Trillion | 5.25% | 0.76x | $810.80 Million |
| Lippo Karawaci Tbk (LPKR) | $23.57 Trillion | -40.88% | 1.20x | $179.43 Million |
| Mitra Keluarga Karyasehat Tbk PT (MIKA) | $3.28 Trillion | 17.29% | 0.13x | $602.27 Million |
| PT Murni Sadar Tbk (MTMH) | $50.49 Billion | 4.95% | 14.96x | $27.98 Million |
| Famon Awal Bros Sedaya (PRAY) | $3.13 Trillion | 6.43% | 0.62x | $52.90 Million |
| PT Charlie Hospital Semarang Tbk (RSCH) | $150.46 Billion | -0.74% | 0.03x | $11.66 Million |
| Kedoya Adyaraya Tbk PT (RSGK) | $751.16 Billion | 3.35% | 0.10x | $3.08 Million |